Dr Alexander M Lesokhin

Go Back

Hematologic Oncologist

  • Memorial Sloan Kettering Cancer Center
  • location United States

Alexander M. Lesokhin, MD, is the Interim Service Chief for the Myeloma Service and a member of the Cellular Therapeutics Center. He is also a member of the Ludwig Collaborative laboratory at Memorial Sloan Kettering Cancer Center in New York, New York. He received his MD from the Albert Einstein College of Medicine with distinction in research. Dr Lesokhin’s research focuses on the ability of cancers to evade the immune system and on developing novel treatments to reverse this process. He leads a portfolio of clinical trials testing the clinical and immune effects of antibodies targeting immune agonists, immune checkpoints, bi-specific engagers and adoptive cellular therapies focused in hematologic malignancies. He has additionally developed and validated assays for measuring myeloid-derived suppressor cells (MDSC) as a potential biomarker for efficacy of immune based therapies. His work has resulted in 70 peer-reviewed publications. Dr Lesokhin has received career development awards from the American Cancer Society and the Melanoma Research Alliance and receives additional funding from Cycle for Survival, the Sawiris Foundation, and the Parker Institute for Cancer Immunotherapy.

Dr Alexander M Lesokhin has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Other programmes developed by Dr Alexander M Lesokhin

podcast Podcast



of 3

Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics

Episode 3: Choosing the Best Treatment Regimen in Patients with High-Risk Cytogenetics

Assoc. Prof. María Victoria Mateos, Dr Alexander M Lesokhin
  • download Downloadable
  • clock 20 MIN
  • calendar Mar 2022

Educational programme supported by an independent medical education grant from Karyopharm